Dipna Pharmachem Ltd — Others, 08-08-2025: Others

DIPNA PHARMACHEM's Board of Directors met and approved an increase in the company's authorized share capital from Rs 25 Cr to Rs 25.50 Cr. This move expands the company's capacity to issue new shares, potentially supporting future growth initiatives. The Board also considered and approved the Director's Report for the financial year 2024-25. Additionally, the company announced its 14th Annual General Meeting, which will be held virtually. These decisions are significant updates for shareholders regarding the company's capital structure and corporate governance.